Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation.

Glutathione (GSH) provides a major source of thiol homeostasis critical to the maintenance of a reduced cellular environment that is conducive to cell survival. Mammals have accumulated a significant cadre of sulfur containing proteins, the interactive significance of which has become clear in recent times. Glutathione transferases (GST) are prevalent in eukaryotes and have been ascribed catalytic functions that involve detoxification of electrophiles through thioether bond formation with the cysteine thiol of GSH. The neutralizing impact of these reactions on products of reactive oxygen has contributed to the significant evolutionary conservation and adaptive functional redundancy of the multifaceted GSH system. Amongst the GSTs, GSTP has been implicated in tumorigenesis and in anticancer drug resistance. Emerging studies indicate that GSTP has ligand binding properties and contributes in the regulation of signaling kinases through direct protein:protein interactions. Furthermore, S-glutathionylation is a post-translational modification of low pK(a) cysteine residues in target proteins. The forward rate of the S-glutathionylation reaction can be influenced by GSTP, whereas the reverse rate is affected by a number of redox sensitive proteins including glutaredoxin, thioredoxin and sulfiredoxin. The functional importance of these reactions in governing how cells respond to oxidative or nitrosative stress exemplifies the broad importance of GSH/GST homeostasis in conditions such as cancer, ageing and neurodegenerative diseases. GSTP has also provided a platform for therapeutic drug development where some agents have completed preclinical testing and are in clinical trial for the management of cancer.

[1]  W. Lowther,et al.  Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. , 2005, Biochemistry.

[2]  C. Smith,et al.  Isolation and characterization of two mouse Pi-class glutathione S-transferase genes. , 1994, The Biochemical journal.

[3]  F. Ali-Osman,et al.  Genetic polymorphism at the glutathione S‐tranferase (GST) P1 locus is a breast cancer risk modifier , 2001, International journal of cancer.

[4]  G. B. Smith,et al.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.

[5]  M. Anderson,et al.  Dynamic state of glutathione in blood plasma. , 1980, The Journal of biological chemistry.

[6]  A. Holmgren,et al.  Catalysis of Thiol/Disulfide Exchange , 2005, Journal of Biological Chemistry.

[7]  Simon C Watkins,et al.  Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. , 1997, Journal of medicinal chemistry.

[8]  Jie Liu,et al.  Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. , 2004, Molecular Cancer Therapeutics.

[9]  D. Townsend,et al.  A novel role for human sulfiredoxin in the reversal of glutathionylation. , 2006, Cancer research.

[10]  W. Nelson,et al.  Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[11]  J. Mieyal,et al.  Glutathione-Thiyl Radical Scavenging and Transferase Properties of Human Glutaredoxin (Thioltransferase) , 2003, The Journal of Biological Chemistry.

[12]  C. Wolf,et al.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Ghibelli,et al.  Proapoptotic activity of new glutathione S-transferase inhibitors. , 2005, Cancer research.

[14]  B. Ketterer,et al.  Ligandin: a Hepatic Protein which Binds Steroids, Bilirubin, Carcinogens and a Number of Exogenous Organic Anions , 1971, Nature.

[15]  A. English,et al.  Protein S-glutathiolation triggered by decomposed S-nitrosoglutathione. , 2004, Biochemistry.

[16]  A. Naing,et al.  Developmental therapeutics for myelodysplastic syndromes. , 2006, The Journal of the National Comprehensive Cancer Network.

[17]  C. Grant,et al.  The yeast Saccharomyces cerevisiae contains two glutaredoxin genes that are required for protection against reactive oxygen species. , 1998, Molecular biology of the cell.

[18]  J. Keck,et al.  Phase 1 Study of TLK286 (Telcyta) Administered Weekly in Advanced Malignancies , 2004, Clinical Cancer Research.

[19]  P. van Bladeren,et al.  Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1. , 1994, Cancer research.

[20]  A. Sorribas,et al.  Grx5 Glutaredoxin Plays a Central Role in Protection against Protein Oxidative Damage inSaccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[21]  K. Schulze-Osthoff,et al.  Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Ozols,et al.  Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. , 1991, Cancer Research.

[23]  M. Pincus,et al.  Regulation of JNK signaling by GSTp , 1999, The EMBO journal.

[24]  K. M. Davies,et al.  JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. , 2003, Molecular cancer therapeutics.

[25]  W. Pearson,et al.  Nomenclature for human glutathione transferases. , 1992, The Biochemical journal.

[26]  K. M. Davies,et al.  PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. , 2006, Journal of medicinal chemistry.

[27]  G. Filomeni,et al.  Glutathione disulfide induces apoptosis in U937 cells by a redox‐mediated p38 mitogen‐activated protein kinase pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Rudolph,et al.  Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. , 2003, Biochemistry.

[29]  K. Tew,et al.  Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. , 2000, Cancer research.

[30]  S. Kohno,et al.  Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. , 1999, Free radical research.

[31]  K. Tew,et al.  Cellular response to a glutathione S-transferase P1-1 activated prodrug. , 2000, Molecular pharmacology.

[32]  L. Kauvar,et al.  Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines , 1996, Cancer Chemotherapy and Pharmacology.

[33]  K. Tew,et al.  Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. , 1991, Biochemical pharmacology.

[34]  K. Tew,et al.  Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. , 1988, Cancer research.

[35]  J. Brooks,et al.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Ghezzi,et al.  Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Piantadosi,et al.  Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. , 2001, Cancer research.

[38]  A. Caccuri,et al.  Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate , 2005, Amino Acids.

[39]  L. Keefer Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. , 2005, Current topics in medicinal chemistry.

[40]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  D. Townsend,et al.  A Glutathione S-Transferase π-Activated Prodrug Causes Kinase Activation Concurrent with S-Glutathionylation of Proteins , 2006, Molecular Pharmacology.

[42]  A. Fisher,et al.  Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. , 2006, Biochemistry.

[43]  E. Burova,et al.  Transactivation of the Epidermal Growth Factor Receptor by Oxidized Glutathione and Its Pharmacological Analogue Glutoxim® in A431 Cells , 2005, Doklady Biological Sciences.

[44]  B. Bennett,et al.  Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation. , 2002, Biochemical pharmacology.

[45]  Wang Al,et al.  Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. , 1985 .

[46]  K. Tew,et al.  Increased Myeloproliferation in Glutathione S-Transferase π-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT Pathways* , 2004, Journal of Biological Chemistry.

[47]  F. G. Hopkins On an Autoxidisable Constituent of the Cell. , 1921, The Biochemical journal.

[48]  Kuo-ping Huang,et al.  Glutathionylation of proteins by glutathione disulfide S-oxide. , 2002, Biochemical pharmacology.

[49]  K. Houk,et al.  On the acidity and reactivity of HNO in aqueous solution and biological systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Feelisch,et al.  Oxidation and Nitrosation of Thiols at Low Micromolar Exposure to Nitric Oxide , 2003, The Journal of Biological Chemistry.

[51]  L. Kauvar,et al.  Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. , 1998, Cancer research.

[52]  M. Spiteri,et al.  Simultaneous identification of GSTP1 Ile105→Val105 and Ala114→Val114 substitutions using an amplification refractory mutation systempolymerase chain reactionassay: studies in patients with asthma , 2001, Respiratory research.

[53]  K. Tew,et al.  Cellular thiols and reactive oxygen species in drug-induced apoptosis. , 2001, The Journal of pharmacology and experimental therapeutics.

[54]  J. Landry,et al.  Activation of the p38 Signaling Pathway by Heat Shock Involves the Dissociation of Glutathione S-Transferase Mu from Ask1* , 2002, The Journal of Biological Chemistry.

[55]  D. Wink,et al.  Discriminating formation of HNO from other reactive nitrogen oxide species. , 2006, Free radical biology & medicine.

[56]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[57]  A. Tulpule,et al.  Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. , 1986, The Journal of biological chemistry.

[58]  M. Lyttle,et al.  Glutathione-S-transferase activates novel alkylating agents. , 1994, Journal of medicinal chemistry.

[59]  D. Forman,et al.  Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. , 1997, Carcinogenesis.

[60]  K. Tew,et al.  Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. , 2001, The Journal of pharmacology and experimental therapeutics.

[61]  E. Wagner,et al.  Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis , 2002, Oncogene.

[62]  S. Rockwell,et al.  1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  F. Ali-Osman,et al.  Structure of the human allelic glutathione S-transferase-pi gene variant, hGSTP1 C, cloned from a glioblastoma multiforme cell line. , 1998, Chemico-biological interactions.

[64]  A. Meister,et al.  Glutathione turnover in the kidney; considerations relating to the gamma-glutamyl cycle and the transport of amino acids. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Strange,et al.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility. , 1999, IARC scientific publications.

[66]  K. Patel,et al.  Multi‐institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S‐transferase P1‐1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer , 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[67]  G. Filomeni,et al.  Cell signalling and the glutathione redox system. , 2002, Biochemical pharmacology.

[68]  D. Townsend,et al.  Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. , 2004, Molecular pharmacology.

[69]  K. Kang,et al.  Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1* , 2001, The Journal of Biological Chemistry.

[70]  K. Tew,et al.  Glutathione S-transferase P1–1 (GSTP1–1) Inhibits c-Jun N-terminal Kinase (JNK1) Signaling through Interaction with the C Terminus* , 2001, The Journal of Biological Chemistry.

[71]  G. Kirby,et al.  Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. , 2006, The Biochemical journal.

[72]  J. Johnson,et al.  Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2,4-dinitrobenzene. , 1992, The Biochemical journal.

[73]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[74]  A. Holmgren,et al.  Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.

[75]  S. Groshen,et al.  Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. , 2002, Journal of the National Cancer Institute.

[76]  K. Tew,et al.  Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. , 1999, The Journal of pharmacology and experimental therapeutics.

[77]  P. B. Chock,et al.  Regulation of PTP1B via glutathionylation of the active site cysteine 215. , 1999, Biochemistry.

[78]  G. Bellí,et al.  Biochemical Characterization of Yeast Mitochondrial Grx5 Monothiol Glutaredoxin* , 2003, Journal of Biological Chemistry.

[79]  D. Wink,et al.  Nitroxyl (HNO): chemistry, biochemistry, and pharmacology. , 2005, Annual review of pharmacology and toxicology.

[80]  M. Chamberlain,et al.  Increased Constitutive c-Jun N-terminal Kinase Signaling in Mice Lacking Glutathione S-Transferase Pi* , 2003, Journal of Biological Chemistry.

[81]  C. Wolf,et al.  Disruption of the glutathione transferase pi class genes. , 2005, Methods in enzymology.

[82]  Clement Ip,et al.  Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. , 2006, Cancer research.

[83]  Giovanni Antonini,et al.  7-Nitro-2,1,3-benzoxadiazole Derivatives, a New Class of Suicide Inhibitors for Glutathione S-Transferases , 2005, Journal of Biological Chemistry.

[84]  K. Tew,et al.  Evidence for a glycoconjugate form of glutathione S-transferase pI. , 2009, International journal of peptide and protein research.

[85]  A. Fisher,et al.  Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. , 2005, Free radical biology & medicine.

[86]  B. Ketterer,et al.  The structure of the human glutathione S-transferase pi gene. , 1988, The Biochemical journal.

[87]  Y. Jiang,et al.  Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals , 2006, Oncogene.

[88]  D. Townsend,et al.  The role of glutathione-S-transferase in anti-cancer drug resistance , 2003, Oncogene.